Barclays PLC Has $4.10 Million Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

Barclays PLC increased its stake in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 390.6% during the third quarter, HoldingsChannel reports. The fund owned 12,937 shares of the industrial products company’s stock after buying an additional 10,300 shares during the period. Barclays PLC’s holdings in UFP Technologies were worth $4,098,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Arizona State Retirement System increased its holdings in shares of UFP Technologies by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 2,032 shares of the industrial products company’s stock worth $536,000 after acquiring an additional 38 shares during the last quarter. Morgan Dempsey Capital Management LLC increased its stake in shares of UFP Technologies by 2.9% during the second quarter. Morgan Dempsey Capital Management LLC now owns 1,459 shares of the industrial products company’s stock worth $385,000 after purchasing an additional 41 shares during the period. Millington Financial Advisors LLC lifted its holdings in UFP Technologies by 0.4% during the 2nd quarter. Millington Financial Advisors LLC now owns 12,737 shares of the industrial products company’s stock worth $3,361,000 after purchasing an additional 51 shares during the last quarter. GAMMA Investing LLC boosted its stake in UFP Technologies by 77.9% in the 3rd quarter. GAMMA Investing LLC now owns 137 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 60 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in UFP Technologies by 67.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 201 shares of the industrial products company’s stock valued at $53,000 after buying an additional 81 shares in the last quarter. Institutional investors own 87.28% of the company’s stock.

Insider Activity

In related news, CEO R Jeffrey Bailly sold 12,533 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total transaction of $4,342,183.18. Following the completion of the sale, the chief executive officer now directly owns 31,194 shares in the company, valued at $10,807,473.24. This represents a 28.66 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Jason Holt sold 146 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $342.69, for a total value of $50,032.74. Following the completion of the sale, the vice president now directly owns 6,721 shares in the company, valued at $2,303,219.49. This trade represents a 2.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 13,326 shares of company stock worth $4,620,154. 6.17% of the stock is currently owned by company insiders.

UFP Technologies Trading Up 2.8 %

Shares of UFPT stock opened at $252.85 on Monday. The stock has a 50 day simple moving average of $295.69 and a 200 day simple moving average of $301.64. UFP Technologies, Inc. has a 1 year low of $152.43 and a 1 year high of $366.41. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64. The stock has a market cap of $1.94 billion, a P/E ratio of 36.07 and a beta of 0.99.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of UFP Technologies from a “hold” rating to a “sell” rating in a research report on Monday, December 16th.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.